CRISPR-cas9 gene editing in undergraduate laboratory experience

被引:0
|
作者
Kee, H. Lynn
Pieczynski, Jay
机构
来源
FASEB JOURNAL | 2019年 / 33卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
617.16
引用
收藏
页数:1
相关论文
共 50 条
  • [21] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Frangoul, H.
    Altshuler, D.
    Cappellini, M. D.
    Chen, Y-S
    Domm, J.
    Eustace, B. K.
    Foell, J.
    de la Fuente, J.
    Grupp, S.
    Handgretinger, R.
    Ho, T. W.
    Kattamis, A.
    Kernytsky, A.
    Lekstrom-Himes, J.
    Li, A. M.
    Locatelli, F.
    Mapara, M. Y.
    de Montalembert, M.
    Rondelli, D.
    Sharma, A.
    Sheth, S.
    Soni, S.
    Steinberg, M. H.
    Wall, D.
    Yen, A.
    Corbacioglu, S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03): : 252 - 260
  • [22] Application of CRISPR-Cas9 gene editing for congenital heart disease
    Seok, Heeyoung
    Deng, Rui
    Cowan, Douglas B.
    Wang, Da-Zhi
    CLINICAL AND EXPERIMENTAL PEDIATRICS, 2021, 64 (06) : 269 - 279
  • [23] Reversible RNA acylation for control of CRISPR-Cas9 gene editing
    Habibian, Maryam
    McKinlay, Colin
    Blake, Timothy R.
    Kietrys, Anna M.
    Waymouth, Robert M.
    Wender, Paul A.
    Kool, Eric T.
    CHEMICAL SCIENCE, 2020, 11 (04) : 1011 - 1016
  • [24] CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
    Fontana, Marianna
    Solomon, Scott D.
    Kachadourian, Jessica
    Walsh, Liron
    Rocha, Ricardo
    Lebwohl, David
    Smith, Derek
    Taubel, Jorg
    Gane, Edward J.
    Pilebro, Bjorn
    Adams, David
    Razvi, Yousuf
    Olbertz, Joy
    Haagensen, Alexandra
    Zhu, Peijuan
    Xu, Yuanxin
    Leung, Adia
    Sonderfan, Alison
    Gutstein, David E.
    Gillmore, Julian D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (23): : 2231 - 2241
  • [25] Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
    Papizan, James B.
    Porter, Shaina N.
    Sharma, Akshay
    Pruett-Miller, Shondra M.
    JOURNAL OF BIOMEDICAL RESEARCH, 2021, 35 (02): : 115 - 134
  • [26] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Mehta, Jayesh
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23):
  • [27] CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential
    Blenke, Erik Oude
    Evers, Martijn J. W.
    Mastrobattista, Enrico
    van der Oost, John
    JOURNAL OF CONTROLLED RELEASE, 2016, 244 : 139 - 148
  • [28] Modelling the Cancer Phenotype in the Era of CRISPR-Cas9 Gene Editing
    Stewart, J.
    Banerjee, S.
    Pettitt, S. J.
    Lord, C. J.
    CLINICAL ONCOLOGY, 2020, 32 (02) : 69 - 74
  • [29] Recent Progress in Regulating CRISPR-Cas9 System for Gene Editing
    Gong Shaohua
    Li Na
    Tang Bo
    ACTA CHIMICA SINICA, 2020, 78 (07) : 634 - 641
  • [30] Is microfluidics the "assembly line" for CRISPR-Cas9 gene-editing?
    Ahmadi, Fatemeh
    Quach, Angela B. V.
    Shih, Steve C. C.
    BIOMICROFLUIDICS, 2020, 14 (06)